Literature DB >> 25678046

Cognitive impairment after chemotherapy related to atypical network architecture for executive control.

Jay F Piccirillo1, Frances Mei Hardin, Joyce Nicklaus, Dorina Kallogjeri, Michael Wilson, Cynthia X Ma, Rebecca S Coalson, Joshua Shimony, Bradley L Schlaggar.   

Abstract

OBJECTIVES: A common complaint of cancer patients is the experience of cognitive difficulty during and after chemotherapy. We hypothesized that cognitive impairment may result from dysfunction in large-scale brain networks, particularly those involved in attentional control.
METHODS: Using a case-control design, this study includes women with a history of invasive ductal or lobular triple-negative breast cancer who completed standard adjuvant chemotherapy within 2 years of study entry. Women who reported cognitive impairment by the Global Rating of Cognition question were considered to be cases (n = 15). Women who reported no cognitive impairment were considered to be controls (n = 13). All enrolled participants were eligible for MRI investigation and underwent resting-state functional connectivity MRI.
RESULTS: Women who self-reported cognitive impairment were found to have disrupted resting-state functional connectivity, as measured by MRI, when compared to women who did not self-report cognitive impairment. These findings suggest that some women may be more sensitive to the standard treatments for breast cancer and that this increased sensitivity may result in functional connectivity alterations in the brain networks supporting attention and executive function.
CONCLUSIONS: Neuroimaging analyses confirmed self-reported cognitive deficits in women with breast cancer treated with chemotherapy.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 25678046      PMCID: PMC4449788          DOI: 10.1159/000370117

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  44 in total

1.  Frequencies contributing to functional connectivity in the cerebral cortex in "resting-state" data.

Authors:  D Cordes; V M Haughton; K Arfanakis; J D Carew; P A Turski; C H Moritz; M A Quigley; M E Meyerand
Journal:  AJNR Am J Neuroradiol       Date:  2001-08       Impact factor: 3.825

2.  A functional MRI study of preparatory signals for spatial location and objects.

Authors:  Maurizio Corbetta; Aaron P Tansy; Christine M Stanley; Serguei V Astafiev; Abraham Z Snyder; Gordon L Shulman
Journal:  Neuropsychologia       Date:  2005-04-26       Impact factor: 3.139

3.  The human brain is intrinsically organized into dynamic, anticorrelated functional networks.

Authors:  Michael D Fox; Abraham Z Snyder; Justin L Vincent; Maurizio Corbetta; David C Van Essen; Marcus E Raichle
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-23       Impact factor: 11.205

4.  Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation.

Authors:  K K Kwong; J W Belliveau; D A Chesler; I E Goldberg; R M Weisskoff; B P Poncelet; D N Kennedy; B E Hoppel; M S Cohen; R Turner
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

5.  Movement-related effects in fMRI time-series.

Authors:  K J Friston; S Williams; R Howard; R S Frackowiak; R Turner
Journal:  Magn Reson Med       Date:  1996-03       Impact factor: 4.668

6.  Anatomic localization and quantitative analysis of gradient refocused echo-planar fMRI susceptibility artifacts.

Authors:  J G Ojemann; E Akbudak; A Z Snyder; R C McKinstry; M E Raichle; T E Conturo
Journal:  Neuroimage       Date:  1997-10       Impact factor: 6.556

7.  Intrinsic signal changes accompanying sensory stimulation: functional brain mapping with magnetic resonance imaging.

Authors:  S Ogawa; D W Tank; R Menon; J M Ellermann; S G Kim; H Merkle; K Ugurbil
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

8.  Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI.

Authors:  Michael D Greicius; Gaurav Srivastava; Allan L Reiss; Vinod Menon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-15       Impact factor: 11.205

Review 9.  Cognitive impairment associated with chemotherapy for cancer: report of a workshop.

Authors:  Ian F Tannock; Tim A Ahles; Patricia A Ganz; Frits S Van Dam
Journal:  J Clin Oncol       Date:  2004-06-01       Impact factor: 44.544

10.  The Cognitive Failures Questionnaire (CFQ) and its correlates.

Authors:  D E Broadbent; P F Cooper; P FitzGerald; K R Parkes
Journal:  Br J Clin Psychol       Date:  1982-02
View more
  16 in total

1.  Peroxisomes contribute to oxidative stress in neurons during doxorubicin-based chemotherapy.

Authors:  Jose F Moruno-Manchon; Ndidi-Ese Uzor; Shelli R Kesler; Jeffrey S Wefel; Debra M Townley; Archana Sidalaghatta Nagaraja; Sunila Pradeep; Lingegowda S Mangala; Anil K Sood; Andrey S Tsvetkov
Journal:  Mol Cell Neurosci       Date:  2017-11-24       Impact factor: 4.314

2.  Cognitive Training for Adults With Bothersome Tinnitus: A Randomized Clinical Trial.

Authors:  Dorina Kallogjeri; Jay F Piccirillo; Edward Spitznagel; Sandra Hale; Joyce E Nicklaus; Frances Mei Hardin; Joshua S Shimony; Rebecca S Coalson; Bradley L Schlaggar
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-05-01       Impact factor: 6.223

3.  Dynamic functional network connectivity reveals the brain functional alterations in lung cancer patients after chemotherapy.

Authors:  Lanyue Hu; Shaohua Ding; Yujie Zhang; Jia You; Song'an Shang; Peng Wang; Xindao Yin; Wenqing Xia; Yu-Chen Chen
Journal:  Brain Imaging Behav       Date:  2021-10-31       Impact factor: 3.978

4.  Comparison of functional dorsal attention network alterations in breast cancer survivors before and after chemotherapy.

Authors:  Chao-Yu Shen; Yuan-Hsiung Tsai; Vincent Chin-Hung Chen; Ming-Chih Chou; Roger S McIntyre; Jun-Cheng Weng
Journal:  Medicine (Baltimore)       Date:  2021-08-20       Impact factor: 1.817

5.  Altered regional homogeneity in patients with ovarian cancer treated with chemotherapy: a resting state fMRI study.

Authors:  Behroze A Vachha; Suril Gohel; James C Root; Maria Kryza-Lacombe; Martee L Hensley; Denise D Correa
Journal:  Brain Imaging Behav       Date:  2021-08-18       Impact factor: 3.224

6.  The Feasibility of Using Metacognitive Strategy Training to Improve Cognitive Performance and Neural Connectivity in Women with Chemotherapy-Induced Cognitive Impairment.

Authors:  Timothy J Wolf; Meghan Doherty; Dorina Kallogjeri; Rebecca S Coalson; Joyce Nicklaus; Cynthia X Ma; Bradley L Schlaggar; Jay Piccirillo
Journal:  Oncology       Date:  2016-07-23       Impact factor: 2.935

7.  Neurotoxic Effects of Anthracycline- vs Nonanthracycline-Based Chemotherapy on Cognition in Breast Cancer Survivors.

Authors:  Shelli R Kesler; Douglas W Blayney
Journal:  JAMA Oncol       Date:  2016-02       Impact factor: 31.777

8.  Increased resting-state cerebellar-cortical connectivity in breast cancer survivors with cognitive complaints after chemotherapy.

Authors:  Hye Yoon Park; Hyeongrae Lee; Joohyuk Sohn; Suk Kyoon An; Kee Namkoong; Eun Lee
Journal:  Sci Rep       Date:  2021-06-08       Impact factor: 4.379

Review 9.  Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events.

Authors:  Ana Dias-Carvalho; Mariana Ferreira; Rita Ferreira; Maria de Lourdes Bastos; Susana Isabel Sá; João Paulo Capela; Félix Carvalho; Vera Marisa Costa
Journal:  Arch Toxicol       Date:  2021-11-02       Impact factor: 5.153

10.  TFEB ameliorates the impairment of the autophagy-lysosome pathway in neurons induced by doxorubicin.

Authors:  Jose Felix Moruno-Manchon; Ndidi-Ese Uzor; Shelli R Kesler; Jeffrey S Wefel; Debra M Townley; Archana Sidalaghatta Nagaraja; Sunila Pradeep; Lingegowda S Mangala; Anil K Sood; Andrey S Tsvetkov
Journal:  Aging (Albany NY)       Date:  2016-12-16       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.